Schedule: Daily subcutaneous injections for 812 weeks (extend to 16 weeks if needed)
Unlike common anti-inflammatories that shut down the healing process, BPC-157 works with your bodys natural repair systems
Occasional reports mention gastrointestinal upset including nausea
Step 3 Receive Your Complete Kit Delivered directly to your door with all required materials, or you can choose to pick it up from our clinic, whichever is more convenient for you
Perilymph drug concentrations were determined at the indicated timepoints
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
